Pacira BioSciences (NASDAQ:PCRX) Target Raised by Needham & Company LLC to $84.00

StockMarketDaily.co reports: Pacira BioSciences stock has undergone multiple analysts rating changes in the recent past.  Pacira BioSciences stock Target Raised by   Needham & Company LLC on 10/18/2021. In a note to investors, the firm issued a new target price of $84.00. The analysts previously had $80.00 target price.

View More Pacira BioSciences (NASDAQ:PCRX) Target Raised by Needham & Company LLC to $84.00